A methodology for assessing treatment response in hashimoto's encephalopathy: A case study demonstrating repeated computerized neuropsychological testing

Journal of Child Neurology

Volumn 26, Issue 6, 2011, Pages 786-791

  Brooks, Brian L ^a,b   Barlow, Karen M ^a,b  

^a ALBERTA CHILDREN'S HOSPITAL   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

autoimmune; computer assessment; neuropsychology; outcome; thyroid

Indexed keywords

ETIRACETAM; LAMOTRIGINE; PHENYTOIN; PREDNISOLONE; THYROID PEROXIDASE ANTIBODY; THYROXINE; TOPIRAMATE;

ADOLESCENT; ARTICLE; CASE REPORT; CLINICAL ASSESSMENT; CLINICAL EXAMINATION; COGNITION; COMPUTER ANALYSIS; CORTICOSTEROID THERAPY; DRUG DOSE INCREASE; DRUG HYPERSENSITIVITY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HASHIMOTO ENCEPHALOPATHY; HUMAN; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; TEMPORAL LOBE EPILEPSY; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADOLESCENT; ATTENTION; BRAIN DISEASES; COGNITION DISORDERS; DIAGNOSIS, COMPUTER-ASSISTED; FEMALE; FOLLOW-UP STUDIES; HASHIMOTO DISEASE; HUMANS; NEUROPSYCHOLOGICAL TESTS; PSYCHOMOTOR PERFORMANCE;

EID: 79957594137     PISSN: 08830738     EISSN: 17088283     Source Type: Journal    
DOI: 10.1177/0883073810391532     Document Type: Article

References (15)

1. Ferraci F., Bertiago G., Moretto G. Hashimoto's encephalopathy: epidemiologic data and pathogenetic considerations. J Neurol Sci. 2004 ; 217: 165-168. (Pubitemid 38056550)
2. Mocellin R., Walterfang M., Velakoulis D. Hashimoto's encephalopathy: epidemiology, pathogenesis and management. CNS Drugs. 2007 ; 21: 799-811. (Pubitemid 47443302)
3. Cummings RR, Bagley SC, Syed S., et al. Hashimoto's encephalopathy: a case report with neuropsychological testing. Gen Hosp Psychiatry. 2007 ; 29: 267-269. (Pubitemid 46695755)
4. Gayatri NA, Whitehouse WP Pilot survey of Hashimoto's encephalopathy in children. Dev Med Child Neurol. 2005 ; 47: 556-558. (Pubitemid 41131615)
5. Gucuyener K., Serdaroglu A., Bideci A., et al. Tremor and myoclonus heralding Hashimoto's encephalopathy. J Pediatr Endocrinol Metab. 2000 ; 13: 1137-1141.
6. Janes SE, Santosh B., Thomas D., Vyas H. Hashimoto's encephalopathy: an unusual cause of seizures in the intensive care unit. Pediatr Crit Care Med. 2004 ; 5: 578-581.
7. Vasconcellos E., Pina-Garza JE, Fakhoury T., Fenichel GM Pediatric manifestations of Hashimoto's encephalopathy. Pediatr Neurol. 1999 ; 20: 394-398. (Pubitemid 29250290)
8. Kothbauer-Margreiter I., Sturzenegger M., Komor J., et al. Encephalopathy associated with Hashimoto's thyroiditis: diagnosis and treatment. J Neurol. 1996 ; 243: 585-593. (Pubitemid 26265825)
9. Jacob S., Rajabally YA Hashimoto's encephalopathy: steroid resistance and response to intravenous immunoglobulins. J Neurol Neurosurg Psychiatry. 2005 ; 76: 455-456. (Pubitemid 40299149)
10. Gualtieri CT, Johnson LG Reliability and validity of a computerized neurocognitive test battery, CNS Vital Signs. Arch Clin Neuropsychol. 2006 ; 21: 623-643. (Pubitemid 44754740)
11. Brooks BL, Iverson GL, Sherman EM, Roberge MC Identifying cognitive problems in children and adolescents with depression using computerized neuropsychological testing. Appl Neuropsychol. 2010 ; 17: 37-43.
12. Gualtieri CT, Johnson LG Efficient allocation of attentional resources in patients with ADHD: maturational changes from age 10 to 29. J Atten Disord. 2006 ; 9: 534-542. (Pubitemid 43171145)
13. Jacobson NS, Truax P. Clinical significance: a statistical approach to defining meaningful change in psychotherapy research. J Consult Clin Psychol. 1991 ; 59: 12-19.
14. Byrne OC, Zuberi SM, Madigan CA, King MD Hashimoto's thyroiditis: a rare but treatable cause of encephalopathy in children. Eur J Paediatr Neurol. 2000 ; 4: 279-282.
15. Huang CW, Pai MC, Tsai JJ Comparative cognitive effects of levetiracetam and topiramate in intractable epilepsy. Psychiatry Clin Neurosci. 2008 ; 62: 548-553.